These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 26518053)

  • 1. Prostaglandin E2-stimulated prostanoid EP4 receptors induce prolonged de novo prostaglandin E2 synthesis through biphasic phosphorylation of extracellular signal-regulated kinases mediated by activation of protein kinase A in HCA-7 human colon cancer cells.
    Fujino H; Seira N; Kurata N; Araki Y; Nakamura H; Regan JW; Murayama T
    Eur J Pharmacol; 2015 Dec; 768():149-59. PubMed ID: 26518053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cyclooxygenase-2 expression by prostaglandin E2 stimulation of the prostanoid EP4 receptor via coupling to Gαi and transactivation of the epidermal growth factor receptor in HCA-7 human colon cancer cells.
    Yoshida K; Fujino H; Otake S; Seira N; Regan JW; Murayama T
    Eur J Pharmacol; 2013 Oct; 718(1-3):408-17. PubMed ID: 23973650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.
    Fujino H; Salvi S; Regan JW
    Mol Pharmacol; 2005 Jul; 68(1):251-9. PubMed ID: 15855407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
    Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K
    FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.
    Fujino H; West KA; Regan JW
    J Biol Chem; 2002 Jan; 277(4):2614-9. PubMed ID: 11706038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of PGE2 on EGF-induced MAP kinase activity and rabbit corneal epithelial proliferation.
    Kang SS; Li T; Xu D; Reinach PS; Lu L
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2164-9. PubMed ID: 10892858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase A.
    Malty RH; Hudmon A; Fehrenbacher JC; Vasko MR
    J Neuroinflammation; 2016 Jul; 13(1):181. PubMed ID: 27400965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
    Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model.
    Parida S; Parekh A; Dey G; Ghosh SC; Mandal M
    Cancer Biol Ther; 2015; 16(6):922-32. PubMed ID: 25894216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.
    Chang HH; Young SH; Sinnett-Smith J; Chou CE; Moro A; Hertzer KM; Hines OJ; Rozengurt E; Eibl G
    Am J Physiol Cell Physiol; 2015 Nov; 309(10):C639-49. PubMed ID: 26310818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation.
    Mendez M; LaPointe MC
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2111-7. PubMed ID: 15626689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of the expression of cyclooxygenase-2 and prostaglandin E
    Kitagawa K; Hamaguchi A; Fukushima K; Nakano Y; Regan JW; Mashimo M; Fujino H
    Eur J Pharmacol; 2022 Apr; 920():174863. PubMed ID: 35240193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells.
    Cherukuri DP; Chen XB; Goulet AC; Young RN; Han Y; Heimark RL; Regan JW; Meuillet E; Nelson MA
    Exp Cell Res; 2007 Aug; 313(14):2969-79. PubMed ID: 17631291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
    Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
    Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 engagement on dendritic cells induces cyclooxygenase-2 and EP2 receptor via p38 and ERK MAPKs.
    Harizi H; Limem I; Gualde N
    Immunol Cell Biol; 2011 Feb; 89(2):275-82. PubMed ID: 20697426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway.
    Xu S; Zhou W; Ge J; Zhang Z
    Mol Med Rep; 2018 Mar; 17(3):4702-4712. PubMed ID: 29328471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation.
    Ogunwobi O; Mutungi G; Beales IL
    Endocrinology; 2006 Sep; 147(9):4505-16. PubMed ID: 16740977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
    Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes.
    Dajani OF; Meisdalen K; Guren TK; Aasrum M; Tveteraas IH; Lilleby P; Thoresen GH; Sandnes D; Christoffersen T
    J Cell Physiol; 2008 Feb; 214(2):371-80. PubMed ID: 17654493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.